Skip to content
← Back to this collection

PUBLICATIONS · 25624430

Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2015 Mar 10
First author
Slomovitz BM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2015 Oct 20;33(30):3516. doi: 10.1200/JCO.2015.61.4636.
    note
    Source null
    related pmid
    26240220
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2015 Oct 20;33(30):3516. doi: 10.1200/JCO.2015.62.5632.
    note
    Source null
    related pmid
    26240222
    relationship
    Comment in

Authors and identifiers

  1. name
    Slomovitz BM
    type
    Author
  2. name
    Jiang Y
    type
    Author
  3. name
    Yates MS
    type
    Author
  4. name
    Soliman PT
    type
    Author
  5. name
    Johnston T
    type
    Author
  6. name
    Nowakowski M
    type
    Author
  7. name
    Levenback C
    type
    Author
  8. name
    Zhang Q
    type
    Author
  9. name
    Ring K
    type
    Author
  10. name
    Munsell MF
    type
    Author
  11. name
    Gershenson DM
    type
    Author
  12. name
    Lu KH
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Slomovitz BM
    type
    Author
  2. name
    Jiang Y
    type
    Author
  3. name
    Yates MS
    type
    Author
  4. name
    Soliman PT
    type
    Author
  5. name
    Johnston T
    type
    Author
  6. name
    Nowakowski M
    type
    Author
  7. name
    Levenback C
    type
    Author
  8. name
    Zhang Q
    type
    Author
  9. name
    Ring K
    type
    Author
  10. name
    Munsell MF
    type
    Author
  11. name
    Gershenson DM
    type
    Author
  12. name
    Lu KH
    type
    Author
bibliography ids
  1. nci-bib-c2b7a3aee57286768eff78ef
book metadata
content sha256
3bbdef1e926b3448e0c0a18be0fbf01548f6b40f4f2c898ef2a51dfc58d83195
document type
citation
dois
  1. 10.1200/JCO.2014.58.3401
electronic publication date
display
2015 Jan 26
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:25624430
immutable id
pubmed:25624430@3bbdef1e926b3448e0c0a18be0fbf01548f6b40f4f2c898ef2a51dfc58d83195
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
8
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
930-6
volume
33
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2015 Oct 20;33(30):3516. doi: 10.1200/JCO.2015.61.4636.
    note
    Source null
    related pmid
    26240220
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2015 Oct 20;33(30):3516. doi: 10.1200/JCO.2015.62.5632.
    note
    Source null
    related pmid
    26240222
    relationship
    Comment in
outcomes validated
false
pmid
25624430
provenance
batch id
863b068fe5a07222af6a
provider
NCBI PubMed ESummary
record sha256
0ba8dcc12558fef4fdb5259e8ddf30de3f7523a506d94cbdef967df9555b5ee5
response sha256
80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
retrieved at
2026-09-09T23:47:07.648963+00:00
publication date
display
2015 Mar 10
precision
day
year
2015
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25624430/
title
Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.

Preserved source evidence · Not medical advice